semaglutide lawsuit update Ozempic update: Here’s what’s going on ⬇️, As of October 18, 2025, lawsuits against Novo Nordisk, the maker of Ozempic (semaglutide), are still ongoing — alleging the drug caused serious side Semaglutide Lawsuit Filed Against Ozempic

Retatrutide has not yet received marketing authorisation from the MHRA or EMA and remains under clinical investigation

Several factors associated with GLP-1 use can contribute to this shift: Rapid weight loss Reduced caloric intake Potential nutrient deficiencies, especially protein, iron, and zinc Hormonal and metabolic changes These changes do not damage the hair follicle itself, which is why the condition is often reversible once the body stabilizes

Long-acting agents might work better for long-term use, especially for patients who might develop movement problems in their digestive system

The critical point here is that Moringa does possess scientifically recognized blood sugar-lowering properties, as detailed in the previous section